Abstracts - faqs.org

Abstracts

Personal finance

Search abstracts:
Abstracts » Personal finance

Rest easy with super

Article Abstract:

REST, the low fee structure of Australia's largest superannuation funds has won the Personal Investor Awards for Excellence in Financial Services 2004. The company's CEO praises the investment skills of the funds consultant, JANA, which recommends the asset allocation, fund managers, and investment strategy.

Author: Hely, Susan
Publisher: Fairfax Business Publication
Publication Name: Personal Investor (Melbourne, Vic.)
Subject: Personal finance
ISSN: 0813-2992
Year: 2004
Investment Offices, Investment Companies, Open-End Investment Funds, Investment Funds & Trusts, Achievements and awards

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


What makes a great investment property

Article Abstract:

Considerable time and effort is required while tracking down good fundamental investment properties. Buyer advocates and advisers provide their professional advice on buying a quality investment property.

Author: Hely, Susan
Publisher: Fairfax Business Publication
Publication Name: Personal Investor (Melbourne, Vic.)
Subject: Personal finance
ISSN: 0813-2992
Year: 2003
Financial management, Methods, Company investment, Property acquisition

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Australia, Investments, Investment management
Similar abstracts:
  • Abstracts: Getting on top of your investment. Making money in a down market
  • Abstracts: The tax factor. Embarking on an investment odyssey
  • Abstracts: More power to your portfolio. Profit margin
  • Abstracts: Ethical approach to investing. New projects no concern
  • Abstracts: Save money on a new mortgage. To love, honor and rebate
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.